If a prescription or over-the-counter drug caused you or a family member to develop Stevens-Johnson syndrome, a lawsuit is often viable — but who you can sue, and what you can recover, depends heavily on whether the drug was a brand-name product or a generic, and whether a prescribing error was involved. A Stevens-Johnson syndrome lawsuit typically proceeds against the drug’s manufacturer for inadequate warnings, against the prescribing physician or pharmacy for negligence, or against both. Verdicts have reached eight figures in the most severe cases, while a 2013 U.S. Supreme Court decision has largely closed the door on claims against makers of generic drugs.
Who You Can Sue
SJS claims generally fall into two categories, and both can appear in the same case.
Product Liability Against the Drug Manufacturer
The most common theory is failure to warn: the manufacturer knew or should have known the drug could cause SJS and did not include adequate warnings on the label. Federal regulations (21 CFR 201.57) require manufacturers to disclose serious adverse reactions, and FDA approval alone does not shield a company from state-law liability if its warnings fell short.1Greg Jones Law. Can I File an SJS Lawsuit Against a Drug Manufacturer Some cases also assert design-defect theories — that the drug was unreasonably dangerous relative to its benefits.
The drugs most often named in these cases include sulfonamide antibiotics (such as Bactrim), the anticonvulsants carbamazepine and lamotrigine (Lamictal), the gout drug allopurinol, and over-the-counter pain relievers like ibuprofen (Motrin, Advil) and naproxen (Aleve).2Cureus. A Compilation of Drug Etiologies of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis3Mayo Clinic. Stevens-Johnson Syndrome Symptoms and Causes
Medical Malpractice Against Prescribers and Pharmacies
Claims against healthcare providers focus on errors in prescribing, dispensing, or monitoring. The most common allegations are prescribing a drug to a patient with a known allergy, failing to follow the manufacturer’s dosing schedule (particularly the slow four-week titration required for lamotrigine), failing to warn patients to watch for rash, and failing to diagnose SJS once early symptoms appeared.4Hanson Fuller. How Medical Negligence Can Lead to Stevens-Johnson Syndrome Pharmacists can also face liability for dispensing without counseling or missing dangerous interactions.5Greg Jones Law. Do Most SJS Cases Settle or Go to Trial
Carbamazepine prescribing has a specific standard-of-care benchmark. The FDA’s label requires screening patients of Asian ancestry for the HLA-B*1502 allele before starting the drug, because carriers face a dramatically higher risk of SJS. Those who test positive should not receive carbamazepine unless the benefit clearly outweighs the risk.6ClinPGx. Carbamazepine (Tegretol) FDA Label Annotation Prescribing without that screening gives a malpractice plaintiff a concrete federal benchmark to point to.
The Generic Drug Barrier
Before investing in a case, know this: if the drug that caused the SJS was a generic, the manufacturer is probably immune from suit. The U.S. Supreme Court’s 2013 decision in Mutual Pharmaceutical Co. v. Bartlett held that federal law preempts state-law design-defect claims against generic manufacturers. Karen Bartlett had developed toxic epidermal necrolysis after taking generic sulindac in 2004; the reaction destroyed roughly two-thirds of her skin and left her nearly blind. A jury awarded her more than $21 million.7Justia. Mutual Pharmaceutical Co. v. Bartlett, 570 U.S. 472
The Supreme Court reversed, 5–4. Because federal law requires generic manufacturers to copy the brand-name label exactly and prohibits them from changing a drug’s composition, they cannot be held liable under state law for failing to do what federal law forbids.7Justia. Mutual Pharmaceutical Co. v. Bartlett, 570 U.S. 472 Combined with the Court’s 2011 ruling in PLIVA v. Mensing, this largely eliminates failure-to-warn and design-defect claims against generic makers — a serious obstacle, since generics account for the vast majority of prescriptions filled in the United States.8Georgetown Law Faculty Publications. Mutual Pharmaceutical Co. v. Bartlett
Brand-name manufacturers are treated differently. Under Wyeth v. Levine (2009), brand-name companies can unilaterally strengthen their warnings through the FDA’s “changes being effected” process, so state failure-to-warn claims against them are not automatically preempted. That distinction is why the biggest SJS verdicts have come against brand-name makers of products like Children’s Motrin.
Even if the manufacturer is beyond reach, a malpractice claim against the prescriber or pharmacy may still be available regardless of whether the drug was brand-name or generic.
What SJS Cases Have Been Worth
Verdicts and settlements vary widely with the severity of injury and the strength of the liability theory.
Reckis v. Johnson & Johnson — $63 Million
The largest reported SJS verdict involved Samantha Reckis, a seven-year-old Massachusetts girl who developed toxic epidermal necrolysis after taking Children’s Motrin in 2003. She lost 90 percent of her skin and 80 percent of her lung capacity, and was left permanently blind.9Top Class Actions. Children’s Motrin SJS Lawsuit Award Upheld by Higher Court In February 2013 a jury awarded $50 million to Samantha and $6.5 million to each parent for loss of consortium.10FindLaw. Reckis v. Johnson and Johnson, SJC-11677
Johnson & Johnson argued that federal law preempted the claim because the FDA had rejected a citizen petition asking that “SJS” and “TEN” be added by name to ibuprofen labels. The Massachusetts Supreme Judicial Court rejected that argument: the FDA had never prohibited warnings about rashes progressing to a life-threatening disease, even if it had rejected the specific disease names. The court affirmed the verdict on April 17, 2015, and the U.S. Supreme Court declined review on January 19, 2016.10FindLaw. Reckis v. Johnson and Johnson, SJC-1167711SCOTUSblog. Johnson and Johnson v. Reckis
Trejo v. Johnson & Johnson — $48.1 Million, Reversed
Christopher Trejo was fifteen when he developed SJS/TEN after taking over-the-counter Motrin in 2005. A Los Angeles jury awarded him $48.1 million in October 2011, including $21.1 million for pain and suffering, $11.4 million for medical expenses and lost earnings, and $15.59 million in punitive damages.12Daily Breeze. Jury Awards Westchester Man $48.1M in Motrin Lawsuit The California Court of Appeal reversed the entire judgment in 2017, finding the design-defect verdicts preempted under Bartlett and the failure-to-warn verdicts internally inconsistent. The case was returned for a new trial limited to failure-to-warn claims.13FindLaw. Trejo v. Johnson and Johnson, B238339
Shaw v. Smith — $40.3 Million, With a Pharmacist on the Hook
A 2025 Georgia appellate decision expanded liability to pharmacists. A patient prescribed lamotrigine for depression developed SJS/TEN after a nurse practitioner escalated the dose far faster than the manufacturer’s recommended schedule, reaching 100 mg just 19 days after starting instead of the standard four-week titration. A jury awarded $40.3 million and apportioned 2 percent of the liability — about $806,000 — to the pharmacist for failing to provide any medication counseling. Both the trial court and the Georgia Court of Appeals upheld that apportionment.14Pharmacy Times. Court Ruling Highlights Risks of Improper Dose Adjustments
Other Verdicts and Settlements
- $10 million (2011, Philadelphia): Brianna Maya, three years old when she took Children’s Motrin in 2000, suffered permanent blindness in one eye. The Pennsylvania Superior Court upheld the verdict in 2014.9Top Class Actions. Children’s Motrin SJS Lawsuit Award Upheld by Higher Court
- $3 million (2018, Illinois): A man wrongly prescribed Bactrim despite a known allergy developed SJS and permanent kidney damage requiring dialysis.15Miller & Zois. Stevens-Johnson Syndrome Lawsuits
- $1.94 million (2012, New Jersey): A twelve-year-old died from SJS after being prescribed Lamictal off-label for behavioral issues. The psychiatrist settled the wrongful death claim.16Blume Forte. Med Mal Stevens-Johnson Syndrome
- $550,000 (2009, Massachusetts): A 28-year-old prescribed Lamictal for postpartum depression developed SJS with burns over 60 percent of her body. The case settled on the eve of trial after evidence showed the prescribing nurse ignored multiple calls from the patient about a developing rash.17Breakstone, White & Gluck. Negligent Prescription of Anti-Anxiety Medication Stevens-Johnson Syndrome
Confidential settlements are common. Publicly described examples include an $8 million settlement covering six plaintiffs, a $5.5 million settlement for two minors, and a $4.1 million single-plaintiff settlement involving severe burns and eye injuries.1Greg Jones Law. Can I File an SJS Lawsuit Against a Drug Manufacturer
What You Can Recover
Economic damages cover quantifiable losses: medical bills (often enormous, given burn-unit care, skin grafts, and eye surgeries), lost wages, projected future earnings when disability prevents a return to work, and out-of-pocket costs for equipment and home modifications.18Greg Jones Law. Recover Damages SJS Lawsuit
Non-economic damages compensate for physical pain, emotional distress (PTSD is common among survivors), disfigurement and scarring, loss of enjoyment of life, and loss of consortium for spouses.18Greg Jones Law. Recover Damages SJS Lawsuit In wrongful death cases, families can recover funeral expenses, lost future income, and loss of companionship. Punitive damages are rare but possible when a manufacturer or provider acted with extreme recklessness, as in the original Trejo verdict’s $15.59 million punitive component before it was overturned.12Daily Breeze. Jury Awards Westchester Man $48.1M in Motrin Lawsuit
The size of any recovery tracks the severity of injury. Stevens-Johnson syndrome carries a mortality rate estimated between 1 and 10 percent, while toxic epidermal necrolysis — the more extreme form, defined by skin detachment over more than 30 percent of the body — can kill up to half of those affected.19ScienceDirect. Emergency Department Evaluation and Management of SJS/TEN Survivors frequently face permanent blindness, chronic respiratory damage, scarring, and organ complications that require lifelong care.20MedlinePlus. Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis
Proving the Drug Caused It
Establishing that a specific drug caused the SJS is often the hardest technical part of these cases. Patients commonly take multiple medications, and skin-biopsy findings look the same regardless of which drug triggered the reaction, so pathology alone cannot identify the culprit.21ScienceDirect. Attribution of Causality in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Clinicians use the ALDEN score (Algorithm of Drug Causality for Epidermal Necrolysis), which weighs the timing between starting a drug and symptom onset, whether the drug was still in the patient’s system, and the drug’s known reputation for triggering SJS.2Cureus. A Compilation of Drug Etiologies of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
Expert testimony is essential. Courts have held that the plaintiff’s expert need not explain the precise biological mechanism, as long as the expert relies on a reliable methodology such as published clinical studies and the temporal relationship between drug exposure and onset.22Expert Institute. Expert Testimony on Stevens-Johnson Syndrome Ruled Admissible
Deadlines and How Cases Are Grouped
Each state sets its own statute of limitations, and there is no single national deadline. Many states apply a “discovery rule” that delays the limitations clock until the patient knew or should have known about the connection between the drug and the injury, which matters because SJS can take time to diagnose and its full consequences may not be apparent immediately.23Dunn Sheehan. SJS Attorneys Even so, evidence degrades and memories fade. Filing sooner is almost always better.
When multiple patients across the country are harmed by the same drug, cases can be consolidated into multidistrict litigation (MDL) before a single federal judge for coordinated discovery and pretrial proceedings, while each plaintiff keeps an individual claim.24Greg Jones Law. What Happens When I Sue for Stevens-Johnson Syndrome Malpractice claims against prescribers, by contrast, are litigated separately in the state where the treatment occurred.